Trosolwg o'r swydd

UCLH Fundraising Team works alongside all Divisions at UCLH, specifically the Strategic Development department, UCLH Charity and other funds across the Trust, to improve the service that we provide for patients. Our vision is to make a difference to all patients at UCLH by investing in projects that add value ‘above and beyond’ standard NHS provision. In recent years, we have delivered fundraising appeals for two high-profile strategic projects including the Grafton Way Building, a new state of the art specialist cancer hospital and precision robotic short stay surgery centre. Other appeals include our Gift of Giving appeal, ‘Bring the Colour’ to our children’s emergency department and radiotherapy department and our Butterfly appeal, to create a sanctuary suite for bereaved parents who have lost their baby. 

The Corporate Fundraising Manager position is a dynamic and pivotal role within the UCLH Fundraising Team. You will be joining us at an important time of growth and ambition, and you will support the expansion and development across the fundraising, communications and philanthropic functions. The fundraising team at UCLH has been in place for nearly five years and has successfully raised more than £10m to date. This is an exciting time to join our small but mighty team as we progress into the next phase of our fundraising strategy and a fantastic opportunity for highly motivated individual with a determined and proactive approach to take the next step in their career.

Prif ddyletswyddau'r swydd

The Corporate Fundraising Manager will report to the Head of Fundraising and work closely with the team to develop a sustainable and dynamic corporate pipeline to support our fundraising income. They will lead on the corporate fundraising strategy, maintaining a portfolio of businesses and organisations in the vicinity. This is an area of growth for the charity and one of significant opportunity as the needs of the Trust intensify. Using their excellent interpersonal skills, they will seek out new corporates relations and connect with them, bringing to life the work UCLH delivers both locally and nationally. The Corporate Fundraising Manager will also work closely with the Communication Team to ensure corporate interest remains committed with campaigns, appeals, and fundraising communications, social media and events. They will support all corporate donation processing, acknowledgements, relationship management, maintain the corporate database, corporate stewardship, and enable us to grow our fundraising capabilities, raising much needed funds for UCLH Charity.

Gweithio i'n sefydliad

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. 
We provide first-class acute and specialist services across eight sites: 
·       University College Hospital (incorporating the Elizabeth Garrett Anderson Wing) 
·       National Hospital for Neurology and Neurosurgery 
·       Royal National ENT and Eastman Dental Hospitals 
·       University College Hospital Grafton Way Building 
·       Royal London Hospital for Integrated Medicine 
·       University College Hospital Macmillan Cancer Centre 
·       The Hospital for Tropical Diseases 
·       University College Hospital at Westmoreland Street 
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology. 
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.